Gina Clark Biography and Net Worth

EVP of Cencora

Gina K. Clark serves as Executive Vice President, Chief Communications & Administration Officer of the Company. She served as Chief Marketing Officer from November 2014 to June 2017. Ms. Clark was named Senior Vice President and Chief Marketing Officer in June 2011. She previously served as Senior Vice President of Marketing and Business Development for AmerisourceBergen Specialty Group from January 2007 to June 2011. Prior to joining the Company, she worked in executive leadership roles at Premier Inc. and HealthSouth, including Senior Vice President of Marketing and Alliance Relations, Group Vice President of Relationship Management, and Senior Vice President of Managed Care and National Contracting.

What is Gina K. Clark's net worth?: The estimated net worth of Gina K. Clark is at least $5.97 million as of February 13th, 2024. Ms. Clark owns 24,802 shares of Cencora stock worth more than $5,974,306 as of April 27th. This net worth evaluation does not reflect any other investments that Ms. Clark may own. Additionally, Ms. Clark receives an annual salary of $1,570,000.00 as EVP at Cencora. Learn More about Gina K. Clark's net worth.
How old is Gina K. Clark?: Ms. Clark is currently 67 years old. There are 7 older executives and no younger executives at Cencora. Learn More on Gina K. Clark's age.
What is Gina K. Clark's salary?: As the EVP of Cencora, Inc., Ms. Clark earns $1,570,000.00 per year. There are 5 executives that earn more than Ms. Clark. The highest earning executive at Cencora is Mr. Steven H. Collis, Chairman, President & CEO, who commands a salary of $5,010,000.00 per year. Learn More on Gina K. Clark's salary.
How do I contact Gina K. Clark?: The corporate mailing address for Ms. Clark and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at [email protected]. Learn More on Gina K. Clark's contact information.
Has Gina K. Clark been buying or selling shares of Cencora?: Gina K. Clark has not been actively trading shares of Cencora in the last ninety days. Most recently, Gina Clark sold 1,100 shares of the business's stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $230.48, for a transaction totalling $253,528.00. Following the completion of the sale, the executive vice president now directly owns 24,802 shares of the company's stock, valued at $5,716,364.96. Learn More on Gina K. Clark's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, insiders at the sold shares 21 times. They sold a total of 7,622,034 shares worth more than $1,640,810,686.31. The most recent insider tranaction occured on April, 16th when CEO Steven H Collis sold 10,754 shares worth more than $2,553,859.92. Insiders at Cencora own 15.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 4/16/2024.

Gina K. Clark Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/13/2024	Sell	1,100	$230.48	$253,528.00	24,802
10/10/2023	Sell	10,695	$187.00	$1,999,965.00	16,038
6/22/2023	Sell	27,542	$186.84	$5,145,947.28	26,733
3/1/2023	Sell	1,924	$156.22	$300,567.28	26,733
12/12/2022	Sell	392	$166.30	$65,189.60	28,657
3/28/2022	Sell	43,704	$153.71	$6,717,741.84
11/12/2021	Sell	16,027	$125.83	$2,016,677.41
4/1/2021	Sell	9,013	$117.94	$1,062,993.22
9/25/2020	Sell	3,097	$94.20	$291,737.40	14,813
7/27/2020	Sell	3,097	$103.38	$320,167.86	16,049
6/26/2020	Sell	3,098	$100.47	$311,256.06	16,667
5/27/2020	Sell	3,098	$90.96	$281,794.08	17,285
4/27/2020	Sell	3,099	$89.60	$277,670.40	17,903
12/4/2019	Sell	10,917	$88.24	$963,316.08
9/19/2019	Sell	7,800	$84.96	$662,688.00	23,595
11/21/2018	Sell	29,549	$88.33	$2,610,063.17	45,344
8/17/2017	Sell	1,273	$80.94	$103,036.62	10,830
3/13/2017	Sell	12,000	$89.03	$1,068,360.00	12,103
8/5/2016	Sell	2,247	$89.50	$201,106.50	9,436
6/23/2015	Sell	3,275	$112.36	$367,979.00
5/5/2015	Sell	1,400	$115.40	$161,560.00

Gina K. Clark Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $240.88

$238.10

$241.36

50 Day Range

MA: $238.55

$231.72

$245.77

2 Week Range

Now: $240.88

$163.37

$246.75

Volume

972,783 shs

Average Volume

1,039,289 shs

Market Capitalization

$48.05 billion

P/E Ratio

26.24

Dividend Yield

0.86%

Beta

0.45

These AI trades triggered this morning (545% return)

From Prosper Trading Academy | Ad

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

Gina Clark Biography and Net Worth

What is Gina K. Clark's net worth?

How old is Gina K. Clark?

What is Gina K. Clark's salary?

How do I contact Gina K. Clark?

Has Gina K. Clark been buying or selling shares of Cencora?

Who are Cencora's active insiders?

Are insiders buying or selling shares of Cencora?